CPT Code 38241: Autologous HPC transplantation billing guide

Key Takeaways

CPT Code 38241 describes autologous hematopoietic progenitor cell (HPC) transplantation, where a patient’s own cells are harvested and reinfused.

38241 differs from CPT 38240 (allogeneic transplantation per donor): 38241 is always the autologous code, billed per infusion event.

Prior authorization is mandatory for virtually all payers; missing it is the single most common denial reason for transplant billing.

Pabau’s claims management software helps transplant center billers track prior auth status, modifier requirements, and claim submission timelines across payers.

CPT Code 38241 is the procedural code for autologous hematopoietic progenitor cell (HPC) transplantation — the reinfusion of a patient’s own previously collected stem or progenitor cells following a myeloablative or reduced-intensity conditioning regimen. It covers the infusion phase only; cell collection is billed separately, and the code is reported per infusion event rather than per donor.

CPT Code 38241: definition, descriptor, and clinical context

According to the American Medical Association (AMA), CPT Code 38241 falls under the Surgery section, Hemic and Lymphatic Systems, within the Transplantation and Post-Transplantation Cellular Infusion Procedures range (38240-38243). The full descriptor reads: Hematopoietic progenitor cell (HPC); autologous transplantation.

In clinical terms, 38241 covers the infusion phase of an autologous transplant. The patient’s own hematopoietic stem or progenitor cells are collected beforehand (a separate billable service) and later reinfused following myeloablative or reduced-intensity conditioning. Because the donor and recipient are the same person, there is no per-donor distinction, which is why the code is billed per infusion event rather than per donor as with allogeneic procedures.

When 38241 applies and when it does not

38241 applies whenever the transplanted cells are autologous, regardless of the collection source (bone marrow, peripheral blood, or umbilical cord blood from the same patient). It does not apply to donor-derived cells. Use Pabau’s claims management software to set up payer-specific claim rules that flag autologous vs. allogeneic code assignments before submission.

The code is also distinct from post-transplantation cellular infusion procedures. If a patient receives a boost infusion after the initial transplant to support hematopoietic recovery, that event may warrant a separate CPT from the 38240-38243 range depending on cell type and source. Document the clinical scenario clearly so the coder can distinguish an initial transplant from a subsequent supportive infusion.

CPT 38241 vs. 38240: autologous vs. allogeneic transplantation

The most common miscoding in this code family is swapping 38240 and 38241. The difference is clinically fundamental and payer-audited.

A key operational detail: 38240 specifies “per donor,” which matters when a single patient receives cells from multiple donors in the same encounter. CPT Code 38241 has no such per-donor qualifier because the source is always the patient. Bill one unit of 38241 per infusion event. If cells are infused on multiple calendar days, each infusion date supports a separate claim line.

Billers at transplant centers using IVF procedure coding workflows will recognize a similar structural logic: distinct collection and infusion phases, each with its own CPT, each requiring clear date-of-service documentation.

Companion codes and the collection phase

CPT Code 38241 covers only the transplantation (infusion) step. The collection of autologous cells is billed separately using one of two companion codes, depending on the harvest method.

• CPT 38206 (Blood-derived HPC harvesting for transplantation, per collection; autologous): Used when cells are mobilized into peripheral blood and collected via apheresis. This is now the most common collection method for autologous transplants in hematologic malignancies.
• CPT 38232 (Bone marrow harvesting for transplantation; autologous): Used when cells are harvested directly from the iliac crest under general or regional anesthesia. Less common today but still used in specific clinical contexts.

Both 38206 and 38241 appear on the same patient account, but they are not billed on the same date of service. The collection occurs days to weeks before conditioning begins. Confirm the claim submission reflects the correct date for each service. Bundling errors where collection and infusion dates are transposed trigger automatic edits at the payer level.

HCPCS S2140 and S2142: when they appear and why they matter

HCPCS Level II codes S2140 and S2142 describe related HPC services for certain non-Medicare payers. However, per Blue Cross Blue Shield of Mississippi medical policy, both S2140 and S2142 appear in the non-covered table for some hematopoietic cell transplantation indications. Check each commercial payer’s coverage policy before submitting these codes, and do not assume they substitute for CPT 38241 with Medicare.

When coding for practices that also handle complex procedural documentation across multiple specialties, coaching CPT code billing workflows offer a useful parallel for understanding how payer-specific coverage tables affect code selection.

ICD-10 diagnosis codes linked to CPT Code 38241

Medical necessity for CPT Code 38241 must be supported by a covered ICD-10-CM diagnosis. Payers use diagnosis codes to determine whether the transplant indication falls within covered benefit criteria. Submitting 38241 with an unrecognized or insufficiently specific ICD-10 code is among the top reasons for initial claim denial.

The CMS Medicare Coverage Database Article A52879 explicitly lists CPT 38241 as a Group 1 code for autologous progenitor cell transplantation in recurrent or refractory neuroblastoma. Additional covered diagnoses appear across several ICD-10 chapters.

Always code to the highest specificity available. C90.00 (multiple myeloma not having achieved remission) will be treated differently by payers than C90.01 (in remission) for autologous transplant indications. The clinical staging documentation in the medical record must match the specificity level of the submitted code.

For inpatient facility billing, CMS confirms the following ICD-10-PCS procedure codes crosswalk to CPT/HCPCS 38241: 30230C0 (Transfusion of Autologous Hematopoietic Stem/Progenitor Cells, Genetically Modified into Peripheral Vein, Open Approach), 30230G0 (Transfusion of Autologous Bone Marrow into Peripheral Vein, Open Approach), and 30230Y0 (Transfusion of Autologous Other Therapeutic Substance into Peripheral Vein, Open Approach). For practices managing complex ICD-10 diagnosis code references workflows across settings, confirming the outpatient vs. inpatient code distinction is critical before submission.

Managing transplant billing across multiple payers?

Pabau's claims management tools help transplant center teams track prior authorization status, flag missing documentation, and submit clean claims the first time. See how it works for high-complexity oncology billing.

Book a demo

Modifiers for CPT 38241 and when to apply them

CPT Code 38241 is a surgical procedure code, which means modifier rules differ from E/M or infusion codes. Not all modifiers are appropriate, and using the wrong one can delay payment or trigger a medical review.

• Modifier 52 (Reduced Services): Used when a planned autologous transplant is partially completed due to clinical complications during the infusion. Document the clinical reason for reduced service in the operative note.
• Modifier 53 (Discontinued Procedure): Applied when the transplant procedure is stopped after anesthesia has been administered and the service initiated, but not completed. Rare in autologous HCT but relevant in conditioning-related emergencies.
• Modifier 22 (Increased Procedural Services): Appropriate when the procedure required substantially more work than typical, such as prolonged infusion management due to a severe infusion reaction. Requires a cover letter and supporting documentation.
• Modifier 76 (Repeat Procedure by Same Physician): Used for a second autologous transplant infusion on the same date or within a close clinical window. Payer prior auth requirements almost always extend to repeat procedures.
• Modifier 90 (Reference Laboratory): Applicable to companion laboratory processing codes, not to 38241 itself, but often appears on the same claim set.

Place of service matters for modifier interpretation. CPT 38241 is performed in a facility (inpatient hospital, BMT unit, or authorized outpatient infusion center). Professional and technical component distinctions do not apply to this global surgery code, but the billing entity (hospital vs. transplant program physician) determines whether the professional component is billed separately.

For transplant centers that also manage outpatient hematology workflows, familiarity with how modifiers interact with ADHD screening CPT codes in multi-specialty practices illustrates how modifier rules shift by procedure category and payer.

Medicare reimbursement and fee schedule

Medicare reimbursement for CPT Code 38241 is set annually through the Physician Fee Schedule (PFS). Because this is a high-complexity surgical procedure performed in a facility setting, the payment reflects the professional component of physician work; the facility fee is billed separately by the hospital or transplant center.

Per the CMS Physician Fee Schedule lookup tool, you can query current work RVU (wRVU), practice expense RVU, and malpractice RVU values for 38241 by locality. Reimbursement rates vary by geographic adjustment factor (GAF), and the 2026 fee schedule values reflect CMS’s annual updates. Always use the current-year PFS data when projecting revenue for transplant program planning.

The CMS Carriers Manual confirms that HCPCS code 38241 is entered in block 24D of Form CMS-1500 for professional billing, which remains the standard submission format for physician services associated with the transplant encounter.

Commercial payer reimbursement and BCBS coverage policies

Commercial payer rates for 38241 vary significantly and are almost universally negotiated through transplant center contracts rather than set by a fee schedule. Blue Cross Blue Shield entities maintain individual medical policies for hematopoietic cell transplantation.

BCBS Florida’s medical policy reflects the AMA’s 2026 annual CPT coding updates for the hematopoietic cell transplantation code family. Transplant centers billing BCBS FL should confirm the updated descriptor language is reflected in their charge capture documentation to avoid claim edits triggered by descriptor mismatches in payer adjudication systems.

For practices managing billing across functional medicine and oncology-adjacent specialties, the payer policy variability for transplant codes underscores why specialty-specific billing protocols should be maintained separately from general practice billing workflows.

Documentation requirements for reimbursement

Insufficient documentation is the second most common reason for 38241 claim denials, after missing prior authorization. Payers conducting post-payment audits look for specific clinical elements that were present on the date of service.

• Transplant indication and diagnosis: The clinical record must document the underlying malignancy or condition, treatment history, and the rationale for autologous transplantation as the appropriate intervention at this stage of care.
• Cell source and collection documentation: Records for the companion collection code (38206 or 38232) must be present and linked to the transplant encounter. This includes apheresis logs or bone marrow harvest procedure notes, cell yield, and cryopreservation records.
• Conditioning regimen: The myeloablative or reduced-intensity conditioning protocol must be documented, typically as a physician order set and nursing administration record.
• Infusion date and time: The transplant date, infusion start and stop times, and supervising physician identity must appear in the record.
• Informed consent: A signed, dated informed consent document specific to the transplant procedure is required by most payers and by HIPAA-governed facility standards.

Using digital forms for structured consent and pre-procedure documentation reduces the risk of incomplete records at audit time. Structured templates capture the required clinical data points consistently across providers within a transplant team.

For practices where HIPAA compliance requirements govern documentation retention, transplant records have extended retention obligations under some state laws beyond the standard HIPAA floor because they involve high-cost, auditable procedures.

Billing workflow tips and denial management

Transplant billing has a higher administrative burden than most surgical services because of the multi-day clinical episode, multiple companion codes, and mandatory prior authorization requirements. A structured pre-submission workflow reduces first-pass denial rates substantially.

• Pre-auth before conditioning starts: Obtain prior authorization for the transplant episode before the patient begins conditioning. Most payers will not retroactively authorize 38241 after infusion has occurred, and appeals for failure to obtain prior auth have a low success rate.
• Link collection and infusion claims: Ensure the apheresis or bone marrow harvest claim (38206 or 38232) processes cleanly before submitting 38241. Some payers require the collection claim to finalize as a prerequisite for authorizing the infusion claim.
• Verify diagnosis code coverage per payer: Not every payer covers every indication for autologous HCT. Pull the relevant LCD or commercial medical policy for each payer before submitting, and confirm the ICD-10 code you are using appears on the covered list.
• Confirm place of service: 38241 must be performed in a covered facility setting. Billing with the wrong place-of-service code (e.g., office instead of inpatient hospital) triggers an automatic edit.
• Watch annual CPT updates: The AMA’s annual CPT coding updates can affect descriptor language across BCBS entities. Verify your charge description master (CDM) reflects the current descriptor before submitting to any BCBS plan.

Transplant programs that use prescription management tools integrated with their clinical documentation systems benefit from tighter links between the conditioning protocol orders and the billing claim, reducing discrepancies that auditors flag.

For teams building denial management workflows across multiple code families, reviewing how ICD-10 diagnostic coding specificity requirements affect coverage determinations provides useful conceptual grounding for the same issues that appear in transplant billing.

Conclusion: billing CPT Code 38241 accurately in 2026

Autologous HPC transplantation is among the most documentation-intensive and financially significant procedures a transplant center bills. CPT Code 38241 covers only the infusion event. Getting the companion codes right, securing prior authorization prospectively, matching ICD-10 specificity to payer coverage tables, and maintaining audit-ready records are the four levers that determine whether a claim pays or triggers a denial cycle.

Practices looking to reduce administrative burden across their oncology and high-complexity billing workflows can explore how oncology-capable EMR software structured around clean claims submission reduces rework and accelerates reimbursement. To see how Pabau supports billing documentation and claims workflows for complex clinical settings, book a demo.

Continue your research

Need a structured approach to managing high-complexity claims? Claims management software helps transplant billers track authorization status, modifier requirements, and submission timelines.

Managing lab and collection workflows alongside transplant billing? Lab management software connects specimen collection documentation to the billing record, reducing companion-code submission errors.

Looking for guidance on broader oncology coding practices? IVF CPT code billing guide covers parallel collection-and-procedure billing logic useful for multi-phase oncology coding workflows.

Frequently Asked Questions